Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-371.81M
↓ 91% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-194.76M
Historical baseline
PeriodValueYoY Change
TTM$-371.81M-3.5%
2024$-359.17M-24.8%
2023$-287.78M-244.5%
2022$-83.52M+47.3%
2021$-158.61M-249.4%
2020$-45.40M+20.4%
2019$-57.04M-